$EVOK
Evoke Pharma Inc

2019 Q2 Form 10-Q Financial Statement

#000156459019017213 Filed on May 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $920.0K $1.220M $1.030M
YoY Change 0.0% 18.45% -14.88%
% of Gross Profit
Research & Development $1.206M $746.9K $1.385M
YoY Change -13.19% -46.09% 79.76%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.124M $746.9K $2.418M
YoY Change -7.91% -69.11% 22.09%
Operating Profit -$2.124M -$2.418M
YoY Change -7.91% 22.09%
Interest Expense $9.642K $0.00 $1.433K
YoY Change 232.14% -100.0% 48.65%
% of Operating Profit
Other Income/Expense, Net $9.642K $0.00 $434.8K
YoY Change 232.25% -100.0% -114.16%
Pretax Income -$2.110M -$1.970M -$1.980M
YoY Change -8.26% -0.51% -60.79%
Income Tax
% Of Pretax Income
Net Earnings -$2.114M -$1.965M -$1.983M
YoY Change -8.21% -0.88% -60.75%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$90.71K -$112.7K -$128.3K
COMMON SHARES
Basic Shares Outstanding 23.26M 17.43M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.440M $4.030M $5.410M
YoY Change 13.94% -25.51% -63.1%
Cash & Equivalents $7.440M $4.029M $5.410M
Short-Term Investments
Other Short-Term Assets $11.55K $11.55K $180.0K
YoY Change -87.17% -93.58% 5.88%
Inventory
Prepaid Expenses $109.7K
Receivables
Other Receivables
Total Short-Term Assets $7.561M $4.260M $5.580M
YoY Change 14.05% -23.66% -62.37%
LONG-TERM ASSETS
Property, Plant & Equipment $70.00K $100.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $69.80K $100.0K $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $7.561M $4.260M $5.580M
Total Long-Term Assets $69.80K $100.0K $0.00
Total Assets $7.631M $4.360M $5.580M
YoY Change 15.1% -21.86% -62.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $410.0K $490.0K $550.0K
YoY Change -6.82% -10.91% 0.0%
Accrued Expenses $880.0K $800.0K $650.0K
YoY Change 7.32% 23.08% 10.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.285M $1.290M $1.196M
YoY Change 1.18% 7.9% 4.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.285M $1.290M $1.196M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.290M $1.290M $1.196M
YoY Change 1.57% 7.9% -82.67%
SHAREHOLDERS EQUITY
Retained Earnings -$73.02M
YoY Change
Common Stock $77.41M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.346M $3.075M $4.389M
YoY Change
Total Liabilities & Shareholders Equity $7.630M $4.360M $5.585M
YoY Change 15.08% -21.93% -62.37%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$2.114M -$1.965M -$1.983M
YoY Change -8.21% -0.88% -60.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.630M -$1.927M -$2.818M
YoY Change -7.39% -31.62% 66.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $636.4K $544.6K
YoY Change 16.85% -92.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.040M 636.4K 544.6K
YoY Change 74.39% 16.85% -92.57%
NET CHANGE
Cash From Operating Activities -1.630M -1.927M -2.818M
Cash From Investing Activities
Cash From Financing Activities 5.040M 636.4K 544.6K
Net Change In Cash 3.410M -1.290M -2.273M
YoY Change 201.77% -43.23% -140.31%
FREE CASH FLOW
Cash From Operating Activities -$1.630M -$1.927M -$2.818M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23261650
CY2019Q1 us-gaap Other Assets Current
OtherAssetsCurrent
11551
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
103252
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
103252
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
378959
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
636432
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2165749
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
393775
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
544643
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3267885
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
4389266
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
378959
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
393775
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-83682
CY2019Q1 evok Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-482878
CY2018Q1 evok Increase Decrease In Accounts Payable And Other Current Liabilities
IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities
-879245
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1926886
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2817966
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
636432
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
544643
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1290454
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7679267
CY2018Q1 evok Reclassification Of Warrant Liability To Equity Due To Amendment Of Warrants
ReclassificationOfWarrantLiabilityToEquityDueToAmendmentOfWarrants
3267885
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ materially from those estimates. </p>
CY2019Q1 evok Entity Incorporation Month And Year Of Incorporation
EntityIncorporationMonthAndYearOfIncorporation
2007-01
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6392311
CY2019Q1 evok Lease Commencement Date
LeaseCommencementDate
2017-01-01
CY2019Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2019-12-31
CY2019Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38000
CY2018Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
35000
CY2019Q1 evok Operating Lease Incremental Borrowing Rate
OperatingLeaseIncrementalBorrowingRate
0.12
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
136000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
136000
CY2007Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
650000

Files In Submission

Name View Source Status
0001564590-19-017213-index-headers.html Edgar Link pending
0001564590-19-017213-index.html Edgar Link pending
0001564590-19-017213.txt Edgar Link pending
0001564590-19-017213-xbrl.zip Edgar Link pending
evok-10q_20190331.htm Edgar Link pending
evok-20190331.xml Edgar Link completed
evok-20190331.xsd Edgar Link pending
evok-20190331_cal.xml Edgar Link unprocessable
evok-20190331_def.xml Edgar Link unprocessable
evok-20190331_lab.xml Edgar Link unprocessable
evok-20190331_pre.xml Edgar Link unprocessable
evok-ex101_436.htm Edgar Link pending
evok-ex102_437.htm Edgar Link pending
evok-ex311_8.htm Edgar Link pending
evok-ex312_9.htm Edgar Link pending
evok-ex321_6.htm Edgar Link pending
evok-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending